Tasting Panel Magazine: Taking the Waters

Mad Tasty Powered by SoRSE

An article in The Tasting Panel Magazine highlighted SōRSE and its partners Aprch™ Beverage Co. , Kleer Sparkling Water and MAD TASTY, commenting, “SōRSE’s success in developing emulsions and flavor profiles that make it convenient for manufacturers to incorporate broad-spectrum #CBD is paving the way for more functional products across a variety of categories.”

SoRSE in Tasting Panel

Read the full article on page 90 in the latest issue of Tasting Panel Magazine.

 

2020: A Year of Innovation & Expansion at SōRSE Technology

2020: A YEAR OF INNOVATION & EXPANSION FOR SORSE

2020 – what a year it has been! At the beginning of the year, the SōRSE team was busy working with our clients who were in the process of developing and launching products and preparing for live events. Then came March, and with it, Covid. Our work world changed, with many employees working remotely. Because SōRSE was deemed an essential business, emulsion production continued, as did the support of our clients. Instead of attending conventions and trade shows, we pivoted to hosting and attending virtual events and offering educational webinars to connect and engage with our partners and community.

 

2020 has been challenging for many reasons, but at SōRSE, there is much to celebrate – including over 1 billion unique views of the articles in which we’ve been featured. Here are some of the highlights from 2020.   

Mary Wagner and Allen Hsieh Join the Board of Directors 

In JanuaryMary Wagner and Allen Hsieh were appointed to the SōRSE Board of DirectorsMary Wagner is a recognized executive leader with a reputable career in the food industry, having created innovative products and developed measures to ensure food quality and safety. Allen Hsieh has over 25 years of experience in business and finance and has managed companies that have generated between $100 million and $500 million in revenue annually.   

OneRepublic’s Ryan Tedder Shares the Story Behind Mad Tasty with Forbes 

In February, Forbes published an interview with Ryan Tedder in which he explains why he decided to start a CBD beverage company, how he discovered SōRSE, and how SōRSE provided the best possible solution for creating his successful beverage line, Mad Tasty 

SōRSE Featured in Bon Appetit’s “How to Find a CBD Product That Works” 

At SōRSE, one of our goals is to educate consumers on the benefits of products that utilize water-soluble emulsion technology. In March, we were able to share our knowledge on “How to Find a CBD Product That Works with Bon Appétit magazine. In the articlewe discuss important topics such as dosing, bioavailability, the differences between different types of CBD products, COAs, and how to figure out if a product is utilizing water-soluble technology. 

First Beverages in Canadian Marketplace Are Powered by SōRSE 

In AprilBenzinga broke the news that the first beverages to reach the Canada’s Cannabis 2.0 market had hit the shelves, and even better, they were powered by SōRSE! Our partner, The Valens Company, collaborated with A1 Cannabis Company to create Summit, a THC Citrus Water, and Basecamp, a CBD Iced Tea. We were proud to see our technology play a part in bringing these drinks to Canadian shelves.  

SōRSE Secures #61 on Fast Co’s Best Workplaces for Innovators List 

In the beginning of AugustSōRSE Technology was included in Fast Co’s Best Workplaces for Innovators list for 2020Nearly 900 companies applied to be recognized by Fast Companyand SōRSE earned position #61 while also being the only cannabis adjacent company included on the list. Fast Company is an influential, cutting-edge magazine focused on “the future of business” with over 16 million monthly unique visitors.  

SōRSE Partners with Pascal Biosciences on Cancer Research 

In SeptemberSōRSE announced that it was entering into a collaborative research agreement with Pascal Biosciences, advancing Pascal’s PAS-393 into clinical testing. Pascal and SōRSE would share their respective technologies to test the cannabinoid PAS-393 in human volunteers; this will enable testing of cancer patients treated with checkpoint inhibitors.  

Donna Wamsley Shares Her Insights on Flavor Trends with Forbes 

Donna Wamsley is not only our Director of Research and Analytics who works on emulsion innovationshe is also a trained flavorist, bringing a depth of knowledge on flavor and creating flavor profiles to her work. In October, Forbes published an interview with Donna in which she discusses her work at SōRSEthe process of becoming a flavorist, and flavor trends she sees emerging in 2021.   

SōRSE Hosts the First Annual SōRSE Summit 

To connect with our partners and share our knowledge with them, SōRSE hosted its first annual, virtual summit in October, featuring presentations for our 50+ clients on a variety of topics on the infused food and beverage marketTopics included: Trends in FlavorEmulsion Customization, Maturation of the Cannabis and CBD Marketplace, amongst many others. 

SōRSE Launches Clear CBD Emulsion 

Near the end of November, we announced the creation of SōRSE Clear, a stable, clear emulsion with a minimal sensory profile. The product made its official debut at our inaugural SōRSE Summit, which was a big win for our Science team and will be a game changer for our customers in the infused beverage space.  

SōRSE Expands into Latin America through Joint Venture with FCM Global 

In November, SōRSE ventured into the Latin American marketplace by announcing a joint venture with FCM Global, based in Medellin, Colombia, which produces organic hemp and cannabis oils. By entering this partnership with FCM, SōRSE is now  licensed to apply its technology to THC, CBD, and other cannabinoids in ColombiaThe emulsion will be branded as “SōRSE by FCM GLOBAL.” 

SōRSE and Pascal Validate and Optimize Cannabinoid Delivery for Cancer Treatment 

Three months after announcing the collaborative research agreementSōRSE and Pascal Biosciences shared the news that they will be moving forward with clinical trials of the cannabinoid PS-393 in 2021 for cancer patients treated with checkpoint inhibitors. This will mark the first pharmaceutical use of SōRSE’s formulation technology in concert with Pascal’s intellectual property.  

Emily Skrobecki Shares Her Experience Working at SōRSE During the Age of Covid with The Business Journals’ Bizwomen 

At the beginning of December, Bizwomen published an essay written by our Process Engineering Manager, Emily Skrobeckiin which she explained how she prioritizes aspects of her job and communicates with her team while working remotely. Emily’s piece illustrates how SōRSE employees are committed to contributing to the company’s success and can adjust the way they work to fit any difficult situation 

 

If you’re interested in learning more about SōRSE and its accomplishments this year, download our Annual Report that summarizes the myriad ways we’ve innovated and expanded our product offerings, services, and production in 2020. We’ve learned a lot from the challenges we faced in 2020 and look forward to the promise and hope that 2021 brings. 

SōRSE & Pascal Optimize Cannabinoid Formulation for Development of Cancer Treatment

Pascal Biosciences and SōRSE Technology Optimize Cannabinoid Formulation for Clinical Development of Cancer Treatment

SEATTLE & VANCOUVER, British Columbia–Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) and SōRSE Technology Corporation (“SōRSE”) have validated and optimized a formula for oral cannabinoid delivery. Their shared efforts are advancing the cannabinoid PAS-393 towards clinical testing against cancer.

“This progress is very promising because this step is critical for testing in human volunteers,” said Pascal CEO Patrick Gray. “We will next identify a drug product manufacturer to prepare our product for testing in cancer patients treated with checkpoint inhibitors.”

It will be the first pharmaceutical use of the novel formulation technology developed by SōRSE and the first clinical trial for Pascal and SōRSE. This collaboration utilizes propriety discoveries by both companies, including Pascal’s intellectual property, which covers the use of cannabinoids in cancer patients treated with checkpoint inhibitors, and SōRSE’s proprietary formulation expertise.

“It’s great to see such rapid progress with the in vitro studies using our formulation technology,” said SōRSE CEO Howard Lee. “We are on track to enter our first clinical trial with Pascal within a year.”

Following characterization of safety and pharmacology in a Phase 1a clinical trial, Pascal and SōRSE may elect to continue clinical development as equal partners in a Phase 1b cancer trial in combination with a checkpoint inhibitor.

About Pascal Biosciences Inc.

Pascal is a biotechnology company targeting innovative therapies for serious diseases, including COVID-19. Pascal is also developing treatments for cancer with targeted therapies for acute lymphoblastic leukemia and cannabinoid-based therapeutics. Pascal’s leading portfolio also comprises a small molecule therapeutic, PAS-403, that is advancing into clinical trials for the treatment of glioblastoma, and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy. For more information, visit www.pascalbiosciences.com.

About SōRSE Technology

SōRSE Technology Corporation is a water-soluble emulsion technology designed for product developers to provide consumers with a better, more consistent cannabinoid experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Its patent-pending technology converts oil into SōRSE, a proprietary water-soluble emulsion, for infusing CBD and other functional ingredients into beverages, food items, topicals, and medical applications. SōRSE Technology currently powers more than 45 leading products in the CBD space. For more information, visit www.sorsetechnology.com.

Contacts

SōRSE Technology Press:
Jon Lindsay Phillips
RLM PR
SorseTech@rlmpr.com
+1-646-828-8566

SōRSE Brings CBD Water-Soluble Emulsion Tech to Colombia with Joint Venture with FCM Global

SoRSE by FCM Global

SEATTLE–SōRSE Technology, the leading water-soluble CBD, hemp, and terpene emulsion provider for infused CPG brands, has announced a joint venture with FCM Global to incorporate a new company in Colombia, drawing on their respective expertise in the cannabis marketplace.

The announcement was made at the Asocolocanna 2nd Forum, the largest cannabis-focused, three-day conference in Colombia, with 400 attendees from government, industry, academia, and research institutes. Four Colombian ministries were represented at the conference: Health and Social Protection, Justice and Law, Sports and Commerce, and Industry and Tourism. Also in attendance were members of other Latin American cannabis associations, including Mexico, Peru, Uruguay, Paraguay, and Argentina. SōRSE Technology was a Platinum Sponsor of the event, and 80 percent of conference-goers attended SōRSE’s VP of Technical Business Development Michael Flemmen’s presentation on water-soluble solutions for infused beverages.

By entering into a joint venture with FCM, SōRSE will now possess a license to apply its technology to THC, CBD, and other cannabinoids in Colombia, as well as a manner in which to export products featuring SōRSE emulsion from Colombia throughout other Central and South American countries. The emulsion will be branded as “SōRSE by FCM GLOBAL.”

“With SōRSE Technology joining FCM Global, the top supplier of cannabis oils, extracts, and isolates, Latin America customers will receive the same low production costs and high quality they have come to expect from FCM – now with water-soluble solutions,” commented Alejandro Marin, Co-Founder and CFO of FCM Global.

FCM Global has committed to providing all required licenses and permits to produce cannabis derivatives in Colombia, working environment, and all labor required for production of SōRSE emulsion. FCM Global will monitor all sales and outreach operations to sell SōRSE and will supply CBD oil (broad-spectrum, distillate, etc.) for conversion to SōRSE products at the current production cost for FCM.

“SōRSE by FCM GLOBAL will deliver safe, stable, and scalable ingredients for Latin America’s product development needs, such as cosmetics, topicals, edibles and pet products,” said Felipe Sanchez, SōRSE Technology’s VP for Latin America. “We are excited to be working in partnership with FCM on this venture and entering into the Latin American marketplace.”

SōRSE has agreed to provide intellectual property, know-how, and equipment to build a SōRSE lab in Colombia, and technical support in sales efforts.

About FCM Global

Company HQ in Medellin, Colombia. Produces organic hemp and cannabis oils, extracts and isolates using its “Co-Sourced Colombia” model to reliably deliver lower production costs and high-quality inputs for domestics and international markets in the nutritional, wellness, pharmaceutical and cosmetic sectors.

Production facilities located in Antioquia and Tolima follow GAP and GMP practices. The 238,800 ft2 FCM Antioquia facility is purpose-built for medical cannabis and the Tolima facility is an extended production facility that covers 474 hectares and will, at full capacity, generate more than 2,300 jobs and 1,000+ tons of cannabis oil per year. This will provide customers with the best and most consistent quality products with lower production cost at large scale.

FCM Global has made the strategic decision and commitment to not compete with our finished product manufacturing clients. Instead, we focus 100% on helping lower our clients’ cost of production by producing/supplying custom CBD extracts, oils, and isolates from Colombia which meet their specific product requirements and support their future new product innovations.

About SōRSE Technology

SōRSE Technology Corporation is a water-soluble emulsion technology designed for product developers to provide consumers with a better, more consistent cannabinoid experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Its patent-pending technology converts oil into SōRSE, a proprietary water-soluble emulsion, for infusing CBD and other functional ingredients into beverages, food items, topicals, and medical applications. SōRSE Technology currently powers more than 45 leading products in the CBD space.

SōRSE is the most consistent, stable, and safe water-soluble solution for integrating CBD and hemp into commercially available products – but it’s also customizable. Our R&D team collaborates with our partners to develop signature formulations that achieve a desired flavor, aroma, or effect to complement each product.

SōRSE implements Good Manufacturing Practices (GMP) and conducts internal and 3rd party testing to produce a Certificate of Analysis for all final materials.

Contacts

Media Contact/SōRSE Technology Press
Jon Lindsay Phillips
RLM PR
SorseTech@rlmpr.com
+1-646-828-8566

BevNET: Trendspotting – CBD Sports Beverages

Trendspotting: CBD Sports Beverages

“Today, consumers are looking for CBD products that are healthier with less sugar, and a sports beverage featuring CBD, minerals, and electrolytes would be a great add to the marketplace.” – Michael Flemmens, VP of Technical Business Development

Read more about how sports drinks are evolving and the market for CBD sports beverages in BevNET’s article.

Press Release: SōRSE Adds Clear Emulsion to Its Product Offerings

SoRSE clear

Seattle, Washington—October 27, 2020—SōRSE Technology, the leading water-soluble CBD, hemp, and terpene emulsion provider for infused CPG brands, announced today its creation of SōRSE Clear, a stable, clear emulsion with a minimal sensory profile. The product made its official debut at SōRSE’s inaugural SōRSE Summit, which was exclusively held for the company’s partners. SōRSE Clear is available immediately for product evaluation.

Clear emulsions are difficult to develop due to the process of getting Refractive Indexes to match. A Refractive Index measures the bending of a ray of light through mediums, with oil droplets that are evenly dispersed reflecting more light. When different Refractive Indexes mix together, the result is a cloudy emulsion. Making a cloudy emulsion turn clear takes months of experimentation trying to match the Refractive Indexes of the oil and water phases.

SōRSE Clear, currently available in isolate, complies with all the main safety and testing protocols, including GMP, GFSI, COA, and FSMA. It contains safe ingredients that are allergen-free and vegan. This clear emulsion can be applied to all product applications, including beverages, nootropics, edibles, topicals, and nutraceuticals.

SōRSE Clear features multiple benefits for product developers, including stability, scalability, safety, bioavailability, improved sensory experience, homogeneity, accurate dosing, and seamless integration.

“2020 has been a year of innovation for SōRSE Technology, and bringing a stable, clear emulsion with minimal sensory impact to market is proof of that,” commented SōRSE CEO Howard Lee. “I’m proud of the work our R&D team did to make this happen. It’s a game-changer for the industry.”

“I’m excited that we are adding a clear emulsion to our core portfolio; this will give formulators and product developers the ability to innovate and to cater to the needs within the global food and beverage market,” said SōRSE Director of Research and Analytics Donna Wamsley. “This unique technology has excellent clarity, minimal sensory properties, and stability.”

About SōRSE Technology

SōRSE Technology Corporation is a water-soluble emulsion technology designed for product developers to provide consumers with a better, more consistent cannabinoid experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Its patent-pending technology converts oil into SōRSE, a proprietary water-soluble emulsion, for infusing CBD and other functional ingredients into beverages, food items, topicals, and medical applications. SōRSE Technology currently powers more than 45 leading products in the CBD space.

SōRSE Technology Press

Jon Lindsay Phillips

RLM PR

SorseTech@rlmpr.com

+1-646-828-8566